ECONIC BIOSCIENCES LIMITED

• ⚠

  Material uncertainty over going concern

  As the group is reliant on obtaining further funding which is not guaranteed to be received, this indicates that a material uncertainty exists that may cast significant doubt on the group's ability to continue as a going concern and therefore may be unable to realise its assets and discharge its liabilities in the normal course of business. The Directors consider that the funding is highly likely to be forthcoming and therefore that the use of going concern basis of preparation is appropriate.

• ◆

  3 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

1. ECONIC BIOSCIENCES LIMITED 2023-02-27 → present
2. AMZL THERAPEUTICS LIMITED 2022-01-11 → 2023-02-27
3. AMZL LIMITED 2021-12-17 → 2022-01-11

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

BDO LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“As the group is reliant on obtaining further funding which is not guaranteed to be received, this indicates that a material uncertainty exists that may cast significant doubt on the group's ability to continue as a going concern and therefore may be unable to realise its assets and discharge its liabilities in the normal course of business. The Directors consider that the funding is highly likely to be forthcoming and therefore that the use of going concern basis of preparation is appropriate.”

Group structure

1. ECONIC BIOSCIENCES LIMITED · parent
   1. Econic Biosciences Inc 100% · USA · Support activity

Significant events

• “Appointment of a full time Chief Scientific Officer (February 2024).”
• “Appointment of a full time Chief Executive Officer (May 2024).”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

9

last 12 months

Capital events

2

last 24 months

Officers appointed

2

last 12 months

Officers resigned

3

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  -24.1%

  £7,971,606 → £6,047,255

• Net assets

  -17.8%

  £8,492,256 → £6,977,367

• Employees

  +150%

  6 → 15

• Operating profit

  -72.7%

  -£3,476,103 → -£6,002,792

• Profit before tax

  -71.4%

  -£3,560,453 → -£6,103,195

• Wages

  +176.6%

  £498,066 → £1,377,533

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers